Cargando…

Potential Cost-Savings From the Use of the Biosimilars in Slovakia

Objectives: To analyse the market shares of biosimilars in Slovakia and to calculate the potential cost-savings from the use of biosimilars in Slovakia based on two different data sources. Methods: National reimbursement lists from the Czech Republic, Hungary, Poland and Slovakia were used for analy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tesar, Tomas, Golias, Peter, Kobliskova, Zuzana, Wawruch, Martin, Kawalec, Paweł, Inotai, András
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472099/ https://www.ncbi.nlm.nih.gov/pubmed/32974261 http://dx.doi.org/10.3389/fpubh.2020.00431

Ejemplares similares

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2021)

Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer
por: Tesar, Tomas, et al.
Publicado: (2017)

Consumption of Antibacterials for Systemic Use in Slovakia: A National Study and the Quality Indicators for Outpatient Antibiotic Use
por: Tesar, Tomas, et al.
Publicado: (2021)

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
por: Kawalec, Paweł, et al.
Publicado: (2017)

Illegal Drug Use among Female University Students in Slovakia
por: Matejovičová, Barbora, et al.
Publicado: (2015)

Desirable but not feasible: Measures and interventions to promote early childhood health and development in marginalized Roma communities in Slovakia
por: Filakovska Bobakova, Daniela, et al.
Publicado: (2022)

What is being done to respond to the rise of chronic diseases and multi-morbidity in Czechia, Hungary, Poland, and Slovakia?
por: Sagan, Anna, et al.
Publicado: (2023)

Editorial: Healthcare organization and delivery strategies, models, and cost savings
por: Xin, Haichang
Publicado: (2023)

Causes and circumstances of accidents at work in the European Union, Slovakia and Czech Republic
por: Hollá, Katarína, et al.
Publicado: (2023)

Somatic Symptoms, Anxiety, and Depression Among College Students in the Czech Republic and Slovakia: A Cross-Sectional Study
por: Gavurova, Beata, et al.
Publicado: (2022)

Readability assessment of package leaflets of biosimilars
por: Piñero-López, María Ángeles, et al.
Publicado: (2019)

The Role of Self-Care Activities (SASS-14) in Depression (PHQ-9): Evidence From Slovakia During the COVID-19 Pandemic
por: Gavurova, Beata, et al.
Publicado: (2022)

Internet Addiction in Socio-Demographic, Academic, and Psychological Profile of College Students During the COVID-19 Pandemic in the Czech Republic and Slovakia
por: Gavurova, Beata, et al.
Publicado: (2022)

Real-World Impact of Switching From Insulin Glargine (Lantus(®)) to Basaglar(®) and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2022)

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts
por: Inotai, Andras, et al.
Publicado: (2018)

Value and Cost Savings From Access to Multi-disciplinary Rehabilitation Services After Severe Acquired Brain Injury
por: Lorenz, Laura S., et al.
Publicado: (2021)

Crisis Communication Saved Lives in Israel
por: Shenhar, Gilead
Publicado: (2014)

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
por: Godman, Brian, et al.
Publicado: (2021)

Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19)
por: Alghamdi, Ahmed N., et al.
Publicado: (2020)

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
por: Mansell, Kerry, et al.
Publicado: (2019)

Healthcare Cost Savings Estimator Tool for Chronic Disease Self-Management Program: A New Tool for Program Administrators and Decision Makers
por: Ahn, SangNam, et al.
Publicado: (2015)

COVID-19 Vaccination Coverage in Italy: How Many Hospitalisations and Related Costs Could Have Been Saved If We Were All Vaccinated?
por: Zamagni, Giulia, et al.
Publicado: (2022)

Attitudes and Perspectives of People Living With Human Immunodeficiency Virus: Findings From the Positive Perspectives Survey in Slovakia
por: Sojak, Lubomir, et al.
Publicado: (2021)

Greater uptake, an alternative reimbursement methodology needed to realize cost-saving potential of oncology biosimilars in the United States
por: Yang, Jingyan, et al.
Publicado: (2021)

Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
por: Mansell, Kerry, et al.
Publicado: (2019)

Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia
por: Lassanova, Monika, et al.
Publicado: (2023)

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review
por: Kawalec, Paweł, et al.
Publicado: (2017)

How Changes in Reimbursement Practices Influence the Financial Sustainability of Medicine Policy: Lessons Learned from Slovakia
por: Tesar, Tomas, et al.
Publicado: (2019)

You’re It—You’ve Got to Save Someone: Immediate Responders, Not Bystanders
por: Ashkenazi, Isaac, et al.
Publicado: (2019)

Impact of daylight saving time on road traffic collision risk: a systematic review
por: Carey, Rachel N, et al.
Publicado: (2017)

Direct and indirect healthcare and carbon savings with ACTIVE Particle Control(TM) air-purification
por: Ereth, Mark, et al.
Publicado: (2023)

Survey of workflow and cost implications of decommissioning regarding the Falsified Medicines Directive in Hungarian hospital pharmacies
por: Vajda, Péter, et al.
Publicado: (2021)

Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System—Insights From the Randomized DETO2X-AMI Trial
por: Hofmann, Robin, et al.
Publicado: (2022)

Prioritizing the First Doses of SARS-CoV-2 Vaccine to Save the Elderly: The Case Study of Italy
por: Pontrelli, Giuseppe, et al.
Publicado: (2021)

Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study
por: Savinkina, Alexandra, et al.
Publicado: (2022)

Biosimilars: How Can Payers Get Long-Term Savings?
por: Mestre-Ferrandiz, Jorge, et al.
Publicado: (2016)

Better future with better us: Exploring young people's energy-saving behavior based on norm activation theory
por: Si, Hongyun, et al.
Publicado: (2022)

Measurement and Prediction of Railway Noise Case Study from Slovakia
por: Němec, Miroslav, et al.
Publicado: (2020)

Characterizing Potentially Preventable Hospitalizations of High-Cost Patients in Rural China
por: Lu, Shan, et al.
Publicado: (2022)

‘It has saved thousands of lives, so why change it?’ Content analysis of objections to cervical screening programme changes in Australia
por: Obermair, Helena M, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lcihrbrkq3kuij94kihilbj57u